Table of Content
Table of Contents
Table of Contents
1 Industry Overview
1.1 Prescription Dermatological Drugs Industry
Figure Prescription Dermatological Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Prescription Dermatological Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Prescription Dermatological Drugs
1.2.2 Downstream
Table Application Segment of Prescription Dermatological Drugs
Table Global Prescription Dermatological Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Prescription Dermatological Drugs Market by Type
3.1 By Type
3.1.1 Anti-acne Drugs
Table Major Company List of Anti-acne Drugs
3.1.2 Anti-aging Drugs
Table Major Company List of Anti-aging Drugs
3.1.3 Dermatitis Drugs
Table Major Company List of Dermatitis Drugs
3.1.4 Hair Loss Drugs
Table Major Company List of Hair Loss Drugs
3.1.5 Psoriasis Drugs
Table Major Company List of Psoriasis Drugs
3.1.6 Skin Cancer Drugs
Table Major Company List of Skin Cancer Drugs
3.1.7 Melasma Drugs
Table Major Company List of Melasma Drugs
3.1.8 Seborrhea Drugs
Table Major Company List of Seborrhea Drugs
3.2 Market Size
Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in USD Million
Figure Global Prescription Dermatological Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in Volume
Figure Global Prescription Dermatological Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Johnson & Johnson (Company Profile, Sales Data etc.)
4.1.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.1.2 Johnson & Johnson Products & Services
4.1.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
4.2.1 Merck Profile
Table Merck Overview List
4.2.2 Merck Products & Services
4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Mylan Pharmaceuticals (Company Profile, Sales Data etc.)
4.4.1 Mylan Pharmaceuticals Profile
Table Mylan Pharmaceuticals Overview List
4.4.2 Mylan Pharmaceuticals Products & Services
4.4.3 Mylan Pharmaceuticals Business Operation Conditions
Table Business Operation of Mylan Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer (Company Profile, Sales Data etc.)
4.5.1 Pfizer Profile
Table Pfizer Overview List
4.5.2 Pfizer Products & Services
4.5.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.6.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.6.2 F. Hoffmann-La Roche Products & Services
4.6.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Allergan (Company Profile, Sales Data etc.)
4.7.1 Allergan Profile
Table Allergan Overview List
4.7.2 Allergan Products & Services
4.7.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Valeant Pharmaceuticals (Company Profile, Sales Data etc.)
4.8.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
4.8.2 Valeant Pharmaceuticals Products & Services
4.8.3 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 PharmaDerm Pharmaceuticals (Company Profile, Sales Data etc.)
4.9.1 PharmaDerm Pharmaceuticals Profile
Table PharmaDerm Pharmaceuticals Overview List
4.9.2 PharmaDerm Pharmaceuticals Products & Services
4.9.3 PharmaDerm Pharmaceuticals Business Operation Conditions
Table Business Operation of PharmaDerm Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Allergan Inamed Corporation (Company Profile, Sales Data etc.)
4.10.1 Allergan Inamed Corporation Profile
Table Allergan Inamed Corporation Overview List
4.10.2 Allergan Inamed Corporation Products & Services
4.10.3 Allergan Inamed Corporation Business Operation Conditions
Table Business Operation of Allergan Inamed Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Prescription Dermatological Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Prescription Dermatological Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Prescription Dermatological Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Prescription Dermatological Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Prescription Dermatological Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Prescription Dermatological Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Prescription Dermatological Drugs Market Concentration, in 2020
Figure Europe Prescription Dermatological Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Prescription Dermatological Drugs MMarket Concentration, in 2020
Figure South America Prescription Dermatological Drugs Market Concentration, in 2020
Figure Middle East & Africa Prescription Dermatological Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
Figure Prescription Dermatological Drugs Demand in Hospital Pharmacies , 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Hospital Pharmacies , 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacies
Figure Prescription Dermatological Drugs Demand in Retail Pharmacies , 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Retail Pharmacies , 2016-2020, in Volume
6.1.3 Demand in Online Pharmacies
Figure Prescription Dermatological Drugs Demand in Online Pharmacies, 2016-2020, in USD Million
Figure Prescription Dermatological Drugs Demand in Online Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Prescription Dermatological Drugs Market Share in 2026, by Application, in USD Million
Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in Volume
Table Prescription Dermatological Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Prescription Dermatological Drugs Production 2016-2020, by Region, in USD Million
Table Prescription Dermatological Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in USD Million
Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in Volume
Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Prescription Dermatological Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Prescription Dermatological Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Figure
List of Table
List of Table
1. Table Upstream Segment of Prescription Dermatological Drugs
2. Table Application Segment of Prescription Dermatological Drugs
3. Table Global Prescription Dermatological Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Anti-aging Drugs
5. Table Major Company List of Dermatitis Drugs
6. Table Major Company List of Hair Loss Drugs
7. Table Major Company List of Psoriasis Drugs
8. Table Major Company List of Skin Cancer Drugs
9. Table Major Company List of Melasma Drugs
10. Table Major Company List of Seborrhea Drugs
11. Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in USD Million
12. Table Global Prescription Dermatological Drugs Market 2016-2020, by Type, in Volume
13. Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in USD Million
14. Table Global Prescription Dermatological Drugs Market Forecast 2021-2026, by Type, in Volume
15. Table Johnson & Johnson Overview List
16. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Merck Overview List
18. Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Bayer Overview List
20. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Mylan Pharmaceuticals Overview List
22. Table Business Operation of Mylan Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Pfizer Overview List
24. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table F. Hoffmann-La Roche Overview List
26. Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Allergan Overview List
28. Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Valeant Pharmaceuticals Overview List
30. Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table PharmaDerm Pharmaceuticals Overview List
32. Table Business Operation of PharmaDerm Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Allergan Inamed Corporation Overview List
34. Table Business Operation of Allergan Inamed Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
35. Table Global Prescription Dermatological Drugs Sales Revenue 2016-2020, by Company, in USD Million
36. Table Global Prescription Dermatological Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
37. Table Global Prescription Dermatological Drugs Sales Volume 2016-2020, by Company, in Volume
38. Table Global Prescription Dermatological Drugs Sales Volume Share 2016-2020, by Company, in Volume
39. Table Regional Demand Comparison List
40. Table Major Application in Different Regions
41. Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in USD Million
42. Table Prescription Dermatological Drugs Demand Forecast 2021-2026, by Application, in Volume
43. Table Prescription Dermatological Drugs Market Growth 2021-2026, by Application, in Volume
44. Table Prescription Dermatological Drugs Market Share in 2026, by Application, in Volume
45. Table Prescription Dermatological Drugs Production 2016-2020, by Region, in USD Million
46. Table Prescription Dermatological Drugs Production 2016-2020, by Region, in Volume
47. Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in USD Million
48. Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in USD Million
49. Table Global Prescription Dermatological Drugs Market 2016-2020, by Region, in Volume
50. Table Global Prescription Dermatological Drugs Market Share 2016-2020, by Region, in Volume
51. Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
52. Table North America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
53. Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
54. Table Europe Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
55. Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
56. Table Asia-Pacific Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
57. Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
58. Table South America Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
59. Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in USD Million
60. Table Middle East & Africa Prescription Dermatological Drugs Market Size 2016-2020, by Country, in Volume
61. Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in USD Million
62. Table Prescription Dermatological Drugs Market Forecast 2021-2026, by Region, in Volume
63. Table Price Factors List